Leading industry experts join the Vertex Chief Strategy Office to shape product innovation and strengthen global compliance strategies for customers KING OF PRUSSIA, Pa., April 10, 2025 (GLOBE ...

Escape From Tarkov has never been one to chase live service trends. Its position as the king of extraction shooters and reputation as one of the most realistic, hardcore FPS games has served it ...

The model, Gemini 2.5 Flash, will soon launch in Vertex AI, Google’s AI development platform. The company says it offers “dynamic and controllable” computing, allowing developers to adjust ...

After another solid year that included 12% growth in the top line, Vertex has bumped up its compensation for CEO Reshma Kewalramani, M.D., to $21.5 million, according to the company’s proxy filing.

Google has launched Vertex AI Media Studio, a suite of generative tools for creating full videos using only text prompts. The platform leverages powerful models, such as Imagen 3 for images ...

Google is adding a new open source framework for building agents to its AI and machine learning platform Vertex AI, along with other updates to help deploy and maintain these agents. It unveiled ...

Shares of Vertex have rallied, even amid the broader stock market sell-off. The company is diversifying beyond its dominance in cystic fibrosis treatments. Several catalysts in 2025 support a ...

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex Pharmaceuticals (NASDAQ: VRTX). Compared to the S&P 500 index, which is down about ...

Vertex Pharmaceuticals (VRTX) announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO in a combination regimen with ivacaftor for the treatment of ...

Peter Marks, the Food and Drug Administration’s top vaccine official, abruptly resigned from the agency on Friday, citing disagreement with Health and Human Services Secretary Robert F. Kennedy Jr.

Such is the spirit of the new Escape From Tarkov event. While it takes a fantastical, survival-horror-inspired leap away from the grounded, milsim aesthetic of the base game, with a new raid ...

Zimislecel (VX-880) pivotal trial on track to complete enrollment and dosing in H1 2025; Vertex expects to submit marketing applications to global regulators in 2026 - Vertex has completed ...